Childhood malignancies in inborn errors of immunity: a multicenter cohort study
European Journal of Pediatrics · 30.10.2026 · 185 (11)
DOI: 10.1007/s00431-026-07575-1 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Pediatrics, online erschienen am 30.10.2026. Verfasst von Serdar Göktaş und 40 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Department of Pediatrics, Division of Pediatric Hematology and Oncology and Pediatric Bone Marrow Transplantation Unit, Erciyes Univ…. Hauptthemen laut MEDLINE: Immunologic Deficiency Syndromes, Neoplasms, Primary Immunodeficiency Diseases. Die Arbeit nennt 37 Literaturangaben. Gefördert von: German Academic Exchange Service.
Abstract (Originalsprache)
Inborn errors of immunity (IEI) increase susceptibility to malignancy, but pediatric multicenter data integrating immune phenotype, molecular findings, treatment, and outcome remain limited. We characterized malignancy patterns and outcomes in children with documented IEI in Türkiye. This retrospective multicenter cohort study included children younger than 18 years with a documented IEI diagnosis and malignancy, irrespective of diagnostic order, across 20 centers from 2000 to 2025. Clinical, molecular, treatment, and outcome data were summarized. Overall survival (OS) was estimated using the Kaplan–Meier method. Across the 20 participating centers, 1,309 children with documented IEI constituted the aggregate center-level reference population; the final analytic cohort included 85 children with documented IEI and malignancy, corresponding to a descriptive center-level frequency of 6.5%. Combined immunodeficiencies with associated or syndromic features were the largest category (49.4%), and ATM was the most frequently reported gene (35.3%). Non-Hodgkin lymphoma was most common (44.7%), followed by Hodgkin lymphoma (23.5%) and acute lymphoblastic leukemia (14.1%). IEI was diagnosed before malignancy in 58 patients (68.2%) and concurrently with or after malignancy in 27 (31.8%). Hematopoietic stem cell transplantation was performed in 17 patients (20.0%). At last documented contact, 38 patients (44.7%) had died; estimated 5-year OS was 70.5% (95% CI, 60.1–82.7), with no statistically significant difference across malignancy categories (log-rank P = 0.73). Conclusion : Childhood malignancy in this referral-based IEI cohort was predominantly lymphoid and occurred across distinct immune and molecular backgrounds. Integrating immune phenotype and molecular context may help guide multidisciplinary cancer assessment and management. What is Known: • Inborn errors of immunity predispose children to malignancy, especially lymphoma. • Pediatric multicenter data integrating immune phenotype, molecular findings, treatment, and outcomes remain limited. What is New: • In this 20-center cohort integrating patient-level immunologic, treatment, and outcome data, IEI was diagnosed concurrently with or after malignancy in 27 of 85 children (31.8%). • All 11 mismatch-repair cases had central nervous system tumors or non-Hodgkin lymphoma; all 9 cases in the Epstein–Barr virus-control/immune-dysregulation group had lymphoma. Estimated 5-year OS was 70.5%. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Faculty, Department of Pediatrics, Division of Pediatric Hematology and Oncology and Pediatric Bone Marrow Transplantation Unit, Erciyes University, Kayseri, Türkiye.
- Department of Pediatrics, Division of Pediatric Immunology and Allergy, Mersin City Education and Research Hospital, Mersin, Türkiye.
- Medical Faculty, Department of Pediatrics, Division of Pediatric Oncology and Pediatric Bone Marrow Transplantation Unit, Çukurova University, Adana, Türkiye.
- Medical Faculty, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Çukurova University, Adana, Türkiye.
- Department of Pediatrics, Division of Pediatric Hematology and Oncology and Pediatric Bone Marrow Transplantation Unit, Bağcılar Medipol Mega University Hospital, Istanbul, Türkiye.
- Medical Faculty, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Sakarya University, Sakarya, Türkiye.
Förderung
- German Academic Exchange Service
Zitieren
APA
Göktaş, S., Güzel, T., Özkan, A., Keskin, Ş., Küpeli, S., Serbes, M., Gök, V., Sezgin, G., Elli, M., Yılmaz, E., Orhan, M. F., Özdemir, Ö., Yağcı, B., Tuncel, D. A., Karaman, K., Kaya, M. Ş., Akbayram, S., Üzel, V. H., Acıpayam, C., …, & Ünal, E. (2026). Childhood malignancies in inborn errors of immunity: a multicenter cohort study. European Journal of Pediatrics, 185(11). https://doi.org/10.1007/s00431-026-07575-1
Vancouver
Göktaş S, Güzel T, Özkan A, Keskin Ş, Küpeli S, Serbes M, et al. Childhood malignancies in inborn errors of immunity: a multicenter cohort study. European Journal of Pediatrics. 2026;185(11). doi:10.1007/s00431-026-07575-1
BibTeX
@article{Gkta2026,
author = {Göktaş, Serdar and Güzel, Turan and Özkan, Ayşe and Keskin, Şuayip and Küpeli, Serhan and Serbes, Mahir and Gök, Veysel and Sezgin, Gülay and Elli, Murat and Yılmaz, Ebru and Orhan, Mehmet Fatih and Özdemir, Öner and Yağcı, Begül and Tuncel, Defne Ay and Karaman, Kamuran and Kaya, Mehmet Şirin and Akbayram, Sinan and Üzel, V Hülya and Acıpayam, Can and Özcan, Alper and Bayram, İbrahim and Kara, Buket and Artaç, Hasibe and Özay, Mustafa and Aktekin, Elif Habibe and Öncel, Kahraman and Yaman, Yöntem and Kıykım, Ayça and Ünüvar, Ayşegül and Karaman, Serap and Tuğcu, Deniz and Polat, Fatma Türkan and Aksoy, Gökalp Rüstem and Temuroğlu, Aytül and Ören, Ayşe Ceyda and Karakükcü, Musa and Boğa, İbrahim and Baş, Hasan and Klein, Christoph and Eken, Ahmet and Ünal, Ekrem},
title = {Childhood malignancies in inborn errors of immunity: a multicenter cohort study},
journal = {European Journal of Pediatrics},
year = {2026},
volume = {185},
number = {11},
doi = {10.1007/s00431-026-07575-1}
}
EUVIMED